...an Australian entrepreneur who previously founded companies including Fibrotech Therapeutics Pty. Ltd., “Trying to raise $7 million for Fibrotech...
...The system is so different now, but there’s still a ways to go,” he said. Fibrotech...

...round (see BioCentury, April 14, 2014) . The firm's most recent exit was fibrosis play Fibrotech Therapeutics Pty. Ltd....

...of orphan disease company Lumena Pharmaceuticals Inc. and a $75 million buyout of renal specialist Fibrotech Therapeutics Pty. Ltd....

...Lumena Pharmaceuticals Inc. for $260 million in cash up front, and rare kidney disease company Fibrotech Therapeutics Pty. Ltd....

...Shire will acquire fibrosis play Fibrotech for $75 million up front, plus undisclosed milestones. Fibrotech's FT011...
...disease that affects the kidney's filtering system and causes serious fibrosis. Shire would also gain Fibrotech's...
...approval by Australia's Foreign Investment Review Board, which Fibrotech expects to take between 30-60 days. Fibrotech Therapeutics Pty. Ltd....

...will acquire fibrosis play Fibrotech Therapeutics Pty. Ltd. (Melbourne, Australia) for $75 million up front, plus undisclosed milestones. Fibrotech's...

...nephropathy associated with Type I or II diabetes is expected to be completed in June. Fibrotech Therapeutics Pty. Ltd....